002620.KS
Jeil Pharma Holdings Inc
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,650.00
+1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.92x
- PEG TTM
- 2.76x
- Price / book
- 0.39x
- Price / sales
- 0.20x
- Price / cash flow
- 10.30x
Enterprise value
- Enterprise value
- KRW 375.6B
- EV / sales
- 0.60x
- EV / EBITDA
- -9.47x
- EV / EBIT
- -89.90x
- Market cap
- KRW 122.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026